...
首页> 外文期刊>Chirality: The pharmacological, biological, and chemical consequences of molecular asymmetry >High-Throughput Chiral LC-MS/MS Method Using Overlapping Injection Mode for the Determination of Pantoprazole Enantiomers in Human Plasma with Application to Pharmacokinetic Study
【24h】

High-Throughput Chiral LC-MS/MS Method Using Overlapping Injection Mode for the Determination of Pantoprazole Enantiomers in Human Plasma with Application to Pharmacokinetic Study

机译:重叠进样的高通量手性LC-MS / MS方法测定人血浆中的azole托拉唑对映体及其在药代动力学研究中的应用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A sensitive and high-throughput chiral liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of R-pantoprazole and S-pantoprazole in human plasma. Sample extraction was carried out by using ethyl acetate liquid-liquid extraction in 96-well plate format. The separation of pantoprazole enantiomers was performed on a CHIRALCEL OJ-RH column and an overlapping injection mode was used to achieve a run time of 5.0 min/sample. The mobile phase consisted of 1) 10 mM ammonium acetate in methanol: acetonitrile (1: 1, v/v) and 2) 20 mM ammonium acetate in water. Isocratic elution was used with flow rate at 500 mu L/min. The enantiomers were quantified on a triple-quadrupole mass spectrometer under multiple reaction monitoring (MRM) mode with m/z 382.1/230.0 for pantoprazole and m/z 388.4/230.1 for pantoprazole-d7. Linearity from 20.0 to 5000 ng/mL was established for each enantiomer (r(2) > 0.99). Extraction recovery ranged from 91.7% to 96.4% for R-pantoprazole and from 92.5% to 96.5% for S-pantoprazole and the IS-normalized matrix factor was 0.98 to 1.07 for R-pantoprazole and S-pantoprazole, respectively. The method was demonstrated with acceptable accuracy, precision, selectivity, and stability and the method was applied to support a pharmacokinetic study of a phase I clinical trial of racemic pantoprazole in healthy Chinese subjects. (C) 2016 Wiley Periodicals, Inc.
机译:建立了灵敏,高通量的手性液相色谱-串联质谱方法,并已用于定量测定人血浆中的R-pan托拉唑和S-pan托拉唑。样品提取是通过使用96孔板形式的乙酸乙酯液-液提取进行的。在CHIRALCEL OJ-RH色谱柱上进行top托拉唑对映体的分离,并采用重叠进样模式实现5.0 min /样品的运行时间。流动相由1)在甲醇中的10 mM乙酸铵:乙腈(1:1:v / v)和2)在水中的20 mM乙酸铵组成。使用等度洗脱,流速为500μL / min。对映异构体在三重四极杆质谱仪上以多反应监测(MRM)模式进行定量,pan托拉唑为m / z 382.1 / 230.0,pan托拉唑-d7为m / z 388.4 / 230.1。每个对映异构体的线性范围为20.0至5000 ng / mL(r(2)> 0.99)。 R-pan托拉唑的提取回收率范围为91.7%至96.4%,S-pan托拉唑的提取回收率范围为92.5%至96.5%,R- top托拉唑和S-pan托拉唑的IS归一化基质因子分别为0.98至1.07。实验证明该方法具有可接受的准确性,精密度,选择性和稳定性,并被用于支持外消旋pan托拉唑在中国健康受试者的I期临床试验中的药代动力学研究。 (C)2016威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号